International Journal of Infectious Diseases
Volume 14, Issue 8 , Pages e677-e681 , August 2010

Risk factors for Mycobacterium ulcerans infection

Received 16 June 2009 ,Revised 25 September 2009 ,Accepted 5 November 2009.

References 

  1. Amofah GK, Sagoe-Moses C, Adjei-Acquah C, Frimpong EH. Epidemiology of Buruli ulcer in Amansie West district, Ghana. Trans R Soc Trop Med Hyg. 1993;87:644–645
  2. Johnson PD, Stinear T, Small PL, Pluschke G, Merritt RW, Portaels F, et al. Buruli ulcer (M. ulcerans infection): new insights, new hope for disease control. PLoS Med. 2005;2:e108
  3. Johnson PD, Hayman JA, Quek TY, Fyfe JA, Jenkin GA, Buntine JA, et al. Consensus recommendations for the diagnosis, treatment and control of Mycobacterium ulcerans infection (Bairnsdale or Buruli ulcer) in Victoria, Australia. Med J Aust. 2007;186:64–68
  4. Noeske J, Kuaban C, Rondini S, Sorlin P, Ciaffi L, Mbuagbaw J, et al. Buruli ulcer disease in Cameroon rediscovered. Am J Trop Med Hyg. 2004;70:520–526
  5. Dega H, Chosidow O, Barete S, Carbonnelle B, Grosset J, Jarlier V. Infection à Mycobacterium ulcerans. Ann Med Interne. 2000;151:339–344
  6. World Health Organization. Buruli ulcer: progress report, 2004-2008. Wkly Epidemiol Rec 2008; 83:145-54.
  7. Johnson PD, Veitch MG, Leslie DE, Flood PE, Hayman JA. The emergence of Mycobacterium ulcerans infection near Melbourne. Med J Aust. 1996;164:76–78
  8. Marston BJ, Diallo MO, Horsburgh CR. Emergence of Buruli ulcer disease in the Daloa region of Côte d’Ivoire. Am J Trop Med Hyg. 1995;52:219–224
  9. Thangaraj HS, Evans RW, Wansbrough-Jones MH. Mycobacterium ulcerans disease; Buruli ulcer. Trans R Soc Trop Med Hyg. 1999;93:337–340
  10. van der Werf TS, van der Graaf WT, Groothuis DG, Knell AJ. Mycobacterium ulcerans infection in Ashanti region. Ghana. Trans R Soc Trop Med Hyg. 1989;83:410–413
  11. van der Werf TS, van der Graaf WT, Tappero JW, Asiedu K. Mycobacterium ulcerans infection. Lancet. 1999;354:1013–1018
  12. Walsh DS, Portaels F, Meyers WM. Buruli ulcer (Mycobacterium ulcerans infection). Trans R Soc Trop Med Hyg. 2008;102:969–978
  13. Asiedu K, Etuaful S. Socioeconomic implications of Buruli ulcer in Ghana: a three-year review. Am J Trop Med Hyg. 1998;59:1015–1022
  14. Debacker M, Aguiar J, Steunou C, Zinsou C, Meyers W, Portaels F. Mycobacterium ulcerans disease: role of age and gender in incidence and morbidity. Trop Med Int Health. 2004;9:1297–1304
  15. Hayman J. Out of Africa: observations on the histopathology of Mycobacterium ulcerans infection. J Clin Pathol. 1993;46:5–9
  16. Pouillot R, Matias G, Wondjie C, Portaels F, Valin N, Ngos F, et al. Risk factors for Buruli ulcer: a case control study in Cameroon. PLoS Negl Trop Dis. 2007;1:e101
  17. Ellen DE, Stienstra Y, Teelken MA, Dijkstra PU, van der Graaf WT, van der Werf., Assessment of functional limitations caused by Mycobacterium ulcerans infection: toward a Buruli ulcer functional limitation score. Trop Med Int Health 2003; 8:90-6.
  18. Stienstra Y, Dijkstra PU, van Wezel MJ, van Roest MH, Beets M, Zijlstra I, et al. Reliability and validity of the Buruli ulcer functional limitation score questionnaire. Am J Trop Med Hyg. 2005;72:449–452
  19. Stienstra Y, van Roest MH, van Wezel MJ, Wiersma IC, Hospers IC, Dijkstra PU, et al. Factors associated with functional limitations and subsequent employment or schooling in Buruli ulcer patients. Trop Med Int Health. 2005;10:1251–1257
  20. Aujoulat I, Johnson C, Zinsou C, Guédénon A, Portaels F. Psychosocial aspects of health seeking behaviours of patients with Buruli ulcer in southern Benin. Trop Med Int Health. 2003;8:750–759
  21. Kibadi Kapay A. Enquête connaissances–attitudes–pratique (CAP) de la population de Songololo (R.D. Congo) sur l’ulcère de Buruli. Bull Soc Pathol Exot. 2004;97:302–305
  22. Stienstra Y, van der Graaf WT, Asamoa K, van der Werf TS. Beliefs and attitudes toward Buruli ulcer in Ghana. Am J Trop Med Hyg. 2002;67:207–213
  23. Mulder AA, Boerma RP, Barogui Y, Zinsou C, Johnson RC, Gbovi J, et al. Healthcare seeking behaviour for Buruli ulcer in Benin: a model to capture therapy choice of patients and healthy community members. Trans R Soc Trop Med Hyg. 2008;102:912–920
  24. Renzaho AM, Woods PV, Ackumey MM, Harvey SK, Kotin J. Community-based study on knowledge, attitude and practice on the mode of transmission, prevention and treatment of the Buruli ulcer in Ga West District, Ghana. Trop Med Int Health. 2007;12:445–458
  25. Sizaire V, Nackers F, Comte E, Portaels F. Mycobacterium ulcerans infection: control, diagnosis, and treatment. Lancet Infect Dis. 2006;6:288–296
  26. Etuaful S, Carbonnelle B, Grosset J, Lucas S, Horsfield C, Phillips R, et al. Efficacy of the combination rifampin–streptomycin in preventing growth of Mycobacterium ulcerans in early lesions of Buruli ulcer in humans. Antimicrob Agents Chemother. 2005;49:3182–3186
  27. World Health Organization. Provisional guidance on the role of specific antibiotics in the management of Mycobacterium ulcerans disease (Buruli ulcer). Geneva: WHO; 2004. Available at: http://www.who.int/buruli/information/antibiotics/en/. (accessed May 28, 2009).
  28. Debacker M, Portaels F, Aguiar J, Stenou C, Zinsou C, Meyers W, et al. Risk factors for Buruli ulcer, Benin. Emerg Infect Dis. 2006;12:1325–1331
  29. Johnson RC, Sopoh GE, Boko M, Zinsou C, Gbovi J, Makoutode M, et al. Distribution de l’infection à Mycobacterium ulcerans (ulcère de Buruli) dans la commune de Lalo au Bénin. Trop Med Int Health. 2005;10:863–871
  30. Stoffel V, Barthelmé B, Chagué F. Ecopathologie tropicale: ulcère de Buruli par monts et par vaux. Sante Publique. 2005;17:191–197
  31. Aguiar J, Steunou C. Les ulcers de Buruli en zone rurale au Bénin: prise en charge de 635 cas. Med Trop 1997; 57:83-90.
  32. Darie H, Le Guyadec T, Touze JE., Aspects épidémiologiques en cliniques de l’ulcère de Buruli en Côte-d’Ivoire: a propos de 124 observations récentes. Bull Soc Pathol Exot 1993; 86:272-6.
  33. Ecra E, Yoboue P, Aka B, Gbery I, Sangare A, Kanga K, et al. Les complications de l’ulcère de Buruli: analyse de 97 cas. Med Afr Noire 2001; 48:154-8.
  34. Hospers IC, Wiersma IC, Dijkstra PU, Stienstra Y, Etuaful S, Ampadu EO, et al. Distribution of Buruli ulcer lesions over body surface area in a large case series in Ghana: uncovering clues for mode of transmission. Trans R Soc Trop Med Hyg. 2005;99:196–201
  35. Kanga JM, Kacou ED, Kouamé K, Kassi K, Kaloga M, Yao JK, et al. La lutte contre l’ulcère de Buruli: expérience de la Côte-d’Ivoire. Bull Soc Pathol Exot. 2006;99:34–38
  36. Phanzu DM, Bafende EA, Dunda BK, Imposo DB, Kibadi AK, Nsiangana SZ, et al. Mycobacterium ulcerans disease (Buruli ulcer) in a rural hospital in Bas-Congo, Democratic Republic of Congo, 2002-2004. Am J Trop Med Hyg. 2006;75:311–314
  37. Portaels F, Aguiar J, Debacker M, Guédénon A, Steunou C, Zinsou C, et al. Mycobacterium bovis BCG vaccination as prophylaxis against Mycobacterium ulcerans osteomyelitis in Buruli ulcer disease. Infect Immun. 2004;72:62–65
  38. Portaels F, Aguiar J, Debacker M, Steunou C, Zinsou C, Guédénon A, et al. Prophylactic effect of Mycobacterium bovis BCG vaccination against osteomyelitis in children with Mycobacterium ulcerans disease (Buruli ulcer). Clin Diagn Lab Immunol. 2002;9:1389–1391
  39. Sopoh GE, Johnson RC, Chauty A, Dossou AD, Aguiar J, Salmon O, et al. Buruli ulcer surveillance, Benin, 2003-2005. Emerg Infect Dis. 2007;13:1374–1376
  40. Teelken MA, Stienstra Y, Ellen DE, Quarshie E, Klutse E, van der Graaf WT, et al. Buruli ulcer: differences in treatment outcome between two centres in Ghana. Acta Trop. 2003;88:51–56
  41. Uganda Buruli Group, Epidemiology of Mycobacterium ulcerans infection (Buruli ulcer) at Kinyara, Uganda. Trans R Soc Trop Med Hyg 1971; 65:763-75.
  42. James K, Attipou KK, James YE, Blakime M, Tignokpa N, Abete B. L’ulcère de Buruli au Togo: à propos d’une enquête hospitalière. Sante 2003; 13:43-7.
  43. Johnson PD, Azuolas J, Lavender CJ, Wishart E, Stinear TP, Hayman JA, et al. Mycobacterium ulcerans in mosquitoes captured during outbreak of Buruli ulcer, southeastern Australia. Emerg Infect Dis. 2007;13:1653–1660
  44. Quek TY, Henry MJ, Pasco JA, O’Brien DP, Johnson PD, Hughes A, et al. Mycobacterium ulcerans infection: factors influencing diagnostic delay. Med J Aust. 2007;187:561–563
  45. Veitch MG, Johnson PD, Flood PE, Leslie DE, Street AC, Hayman JA. A large localized outbreak of Mycobacterium ulcerans infection on a temperate southern Australian island. Epidemiol Infect. 1997;119:313–318
  46. Quek TY, Athan E, Henry MJ, Pasco JA, Redden-Hoare J, Hughes A, et al. Risk factors for Mycobacterium ulcerans infection, southeastern Australia. Emerg Infect Dis. 2007;13:1661–1666
  47. Raghunathan PL, Whitney EA, Asamoa K, Stienstra Y, Taylor TH, Amofah GK, et al. Risk factors for Buruli ulcer disease (Mycobacterium ulcerans infection): results from a case–control study in Ghana. Clin Infect Dis. 2005;40:1445–1453
  48. Stienstra Y, van der Werf TS, van der Graaf WT, Secor WE, Kihlstrom SL, Dobos KM, et al. Buruli ulcer and schistosomiasis: no association found. Am J Trop Med Hyg. 2004;71:318–321
  49. Nackers F, Dramaix M, Johnson RC, Zinsou C, Robert A, Biurrun Bakedano DE, et al. BCG vaccine effectiveness against Buruli ulcer: a case–control study in Benin. Am J Trop Med Hyg. 2006;75:768–774
  50. Aiga H, Amano T, Cairncross S, Adomako J, Nanas OK, Coleman S. Assessing water-related risk factors for Buruli ulcer: a case–control study in Ghana. Am J Trop Med Hyg. 2004;71:387–392
  51. Nackers F, Johnson RC, Glynn JR, Zinsou C, Tonglet R, Portaels F. Environmental and health-related risk factors for Mycobacterium ulcerans disease (Buruli ulcer) in Benin. Am J Trop Med Hyg. 2007;77:834–836
  52. Wagner T, Benbow ME, Brenden TO, Qi J, Johnson RC. Buruli ulcer disease prevalence in Benin, West Africa: associations with land use/cover and the identification of disease clusters. Int J Health Geogr. 2008;7:25
  53. Johnson RC, Nackers F, Glynn JR, de Biurrun Bakedano E, Zinsou C, Aguiar J, et al. Association of HIV infection and Mycobacterium ulcerans disease in Benin. AIDS. 2008;22:901–903
  54. Barker DJ, Carswell JW. Mycobacterium ulcerans infection among tsetse control workers in Uganda. Int J Epidemiol. 1973;2:161–165
  55. Barker DJ, Ninkibigaya V. Buruli disease and patients’ activities. East Afr Med J. 1972;49:260–268
  56. Duker AA, Portaels F, Hale M. Pathways of Mycobacterium ulcerans infection: a review. Environ Int. 2006;32:567–573
  57. Merritt RW, Benbow ME, Small PL. Unraveling an emerging disease associated with disturbed aquatic environments: the case of Buruli ulcer. Front Ecol Environ. 2005;3:323–331
  58. Ross BC, Johnson PD, Oppedisano F. Detection of Mycobacterium ulcerans in environmental samples during an outbreak of ulcerative disease. Appl Environ Microbiol. 1997;63:4135–4138
  59. Stinear T, Davies JK, Jenkin GA, Hayman JA, Oppedisano F, Johnson PD. Identification of Mycobacterium ulcerans in the environment from regions in southeast Australia in which it is endemic with sequence capture-PCR. Appl Environ Microbiol. 2000;66:3206–3213
  60. Williamson HR, Benbow ME, Nguyen KD, Beachboard DC, Kimbirauskas RK, McIntosh MD, et al. Distribution of Mycobacterium ulcerans in Buruli ulcer endemic and non-endemic aquatic sites in Ghana. PLoS Negl Trop Dis. 2008;2:e205
  61. Eddyani M, Ofori-Adjei D, Teugels G, De Weirdt D, Boakye D, Meyers WM, et al. Potential role for fish in transmission of Mycobacterium ulcerans disease (Buruli ulcer): an environmental study. Appl Environ Microbiol. 2004;70:5679–5681
  62. Kotlowski R, Martin A, Ablordey A, Chemlal K, Fonteyne PA, Portaels F. One-tube cell lysis and DNA extraction procedure for PCR-based detection of Mycobacterium ulcerans in aquatic insects, molluscs and fish. J Med Microbiol. 2004;53:927–933
  63. Meyers WM, Shelly WM, Connor DH, Meyers EK. Human Mycobacterium ulcerans infections developing at sites of trauma to skin. Am J Trop Med Hyg. 1974;23:919–923
  64. Hayman J. Postulated epidemiology of Mycobacterium ulcerans infection. Int J Epidemiol. 1991;20:1093–1098
  65. Johnson PD, Lavender CJ. Correlation between Buruli ulcer and vector-borne notifiable diseases, Victoria. Australia. Emerg Infect Dis. 2009;15:614–615
  66. Portaels F, Elsen P, Guimaraes-Peres A, Fonteyne PA, Meyers WM. Insects in the transmission of Mycobacterium ulcerans infection. Lancet. 1999;353:986
  67. Portaels F, Meyers WM, Ablordey A, Castro AG, Chemlal K, de Rijk P, et al. First cultivation and characterization of Mycobacterium ulcerans from the environment. PLoS Negl Trop Dis. 2008;2:e178
  68. Benbow ME, Williamson H, Kimbirauskas R, McIntosh MD, Kolar R, Quaye C, et al. Aquatic invertebrates as unlikely vectors of Buruli ulcer disease. Emerg Infect Dis. 2008;14:1247–1254
  69. Marsollier L, Stinear T, Aubry J, Saint André JP, Robert R, Legras P, et al. Aquatic plants stimulate the growth of and biofilm formation by Mycobacterium ulcerans in axenic culture and harbor these bacteria in the environment. Appl Environ Microbiol. 2004;70:1097–1103

PII: S1201-9712(10)00031-7

doi: 10.1016/j.ijid.2009.11.013

International Journal of Infectious Diseases
Volume 14, Issue 8 , Pages e677-e681 , August 2010

Article Tools